Supersapiens Glucose Platform

Supersapiens partnered with Abbott to bring the first continuous glucose monitoring (CGM) platform to competitive athletes. While the technology was groundbreaking, athletes struggled to derive actionable insights from complex glucose data.

The business challenge was equally critical: how do you scale a highly technical product across multiple platforms (mobile, web, wearable integrations) while maintaining FDA compliance requirements and managing limited resources?

I developed a phased rollout strategy that transformed complex glucose data into progressive, digestible insights. Each phase built upon the previous, creating a scaffolded learning experience that grew with the athlete's understanding.

Each phase was carefully designed to introduce complexity gradually, ensuring athletes could build understanding before adding new dimensions of analysis. The strategy balanced immediate value delivery with long-term platform capabilities.

I led the development of comprehensive product roadmaps spanning mobile apps, web portal, and third-party integrations. The strategy balanced immediate business needs with long-term product vision while managing FDA submission requirements.

Built affiliate partner portal enabling nutritionists and coaches to manage multiple athletes, place bulk orders, and access shared resources. This B2B2C strategy opened new revenue streams while enhancing the core product's value proposition for individual athletes.

Phase 1 Success: The Contextualize release in Fall 2022 drove immediate sales growth by making glucose data understandable and actionable for the first time. Athletes could finally see how their training impacted recovery and vice versa.

Platform Scalability: Established dual-track product management framework in Jira that enabled parallel development across mobile, web, and integrations while managing FDA compliance requirements.

Partner Ecosystem: Successfully coordinated major integrations with Garmin (Epix, 955 Solar), Wahoo (Bolt, Roam), and established foundation for future partnerships with Oura Ring and Apple HealthKit.

Operational Efficiency: Implemented multi-tier support triage and automated reporting systems that reduced overhead while scaling the platform to support growing user base.

Phased rollouts reduce risk: Breaking complex product visions into progressive releases allowed us to validate assumptions, gather user feedback, and adjust strategy while maintaining development momentum.

Scaffolded learning drives adoption: By introducing features in a logical progression (Contextualize → Personalize → Synthesize → Customize), we reduced cognitive load and improved feature adoption rates.

Partner coordination is critical: Managing dependencies across Abbott (biosensor), Garmin/Wahoo (integrations), and FDA (regulatory) required proactive communication and flexible roadmap planning.

Dual-track agile enables speed: Implementing parallel discovery and delivery tracks allowed us to maintain aggressive timelines while ensuring quality and strategic alignment.